

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.36934026 |
| 2 | protein localization to synapse (GO:0035418) | 5.27638995 |
| 3 | dendritic spine morphogenesis (GO:0060997) | 5.27103381 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.93705236 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.87877163 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.82257900 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.79928856 |
| 8 | mannose metabolic process (GO:0006013) | 4.70347762 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 4.66159348 |
| 10 | central nervous system myelination (GO:0022010) | 4.66159348 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.62282009 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.52365499 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.49761598 |
| 14 | exploration behavior (GO:0035640) | 4.42844791 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.37738630 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.34585618 |
| 17 | synaptic vesicle maturation (GO:0016188) | 4.33565786 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.16017033 |
| 19 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.10665480 |
| 20 | glutamate secretion (GO:0014047) | 3.97062647 |
| 21 | neuron recognition (GO:0008038) | 3.96595800 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.95654135 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90844955 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.89028228 |
| 25 | regulation of synapse maturation (GO:0090128) | 3.84949556 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.81350139 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.80143367 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.78554854 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78554854 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.78187744 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.77080174 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.74045273 |
| 33 | thymic T cell selection (GO:0045061) | 3.71936241 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.68853110 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.68153682 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68058835 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64745653 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63982726 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.63455274 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.62835925 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57731518 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.55241847 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 3.54486113 |
| 44 | dendritic spine organization (GO:0097061) | 3.52134485 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.50735772 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.50068534 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.49330761 |
| 48 | regulation of vesicle fusion (GO:0031338) | 3.49024102 |
| 49 | presynaptic membrane organization (GO:0097090) | 3.47880860 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.44737865 |
| 51 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.44484266 |
| 52 | positive regulation of dendritic spine development (GO:0060999) | 3.37956999 |
| 53 | T cell selection (GO:0045058) | 3.36776242 |
| 54 | axonal fasciculation (GO:0007413) | 3.34115905 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30647517 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.29649089 |
| 57 | negative T cell selection (GO:0043383) | 3.29385064 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28458967 |
| 59 | positive T cell selection (GO:0043368) | 3.26194887 |
| 60 | synaptic transmission, glutamatergic (GO:0035249) | 3.25130239 |
| 61 | long-term memory (GO:0007616) | 3.24119158 |
| 62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.22530568 |
| 63 | histone H3-K36 demethylation (GO:0070544) | 3.21741855 |
| 64 | positive regulation of synapse assembly (GO:0051965) | 3.21304570 |
| 65 | regulation of ARF GTPase activity (GO:0032312) | 3.20843694 |
| 66 | neuron-neuron synaptic transmission (GO:0007270) | 3.17568812 |
| 67 | postsynaptic membrane organization (GO:0001941) | 3.17167222 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 3.15809264 |
| 69 | regulation of bile acid biosynthetic process (GO:0070857) | 3.12634405 |
| 70 | neuronal ion channel clustering (GO:0045161) | 3.09074575 |
| 71 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.08170228 |
| 72 | germinal center formation (GO:0002467) | 3.07504883 |
| 73 | regulation of glutamate secretion (GO:0014048) | 3.07210667 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06987363 |
| 75 | regulation of axon extension (GO:0030516) | 3.06482483 |
| 76 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.06218278 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 3.04664600 |
| 78 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.02335275 |
| 79 | negative regulation of protein localization to cell surface (GO:2000009) | 3.02302245 |
| 80 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.02279665 |
| 81 | regulation of synaptic vesicle transport (GO:1902803) | 3.01250562 |
| 82 | neurotransmitter secretion (GO:0007269) | 3.00519336 |
| 83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00100756 |
| 84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00100756 |
| 85 | modulation by symbiont of host immune response (GO:0052553) | 3.00100756 |
| 86 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00100756 |
| 87 | modulation by symbiont of host defense response (GO:0052031) | 3.00100756 |
| 88 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00100756 |
| 89 | negative regulation of axon extension (GO:0030517) | 2.99461112 |
| 90 | behavioral response to cocaine (GO:0048148) | 2.98775736 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.98591486 |
| 92 | membrane depolarization (GO:0051899) | 2.97144389 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97074086 |
| 94 | dendrite morphogenesis (GO:0048813) | 2.94166261 |
| 95 | long-term synaptic potentiation (GO:0060291) | 2.93749184 |
| 96 | detection of bacterium (GO:0016045) | 2.92567549 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.92556334 |
| 98 | regulation of dendritic spine development (GO:0060998) | 2.92465348 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92342286 |
| 100 | detection of other organism (GO:0098543) | 2.89623734 |
| 101 | regulation of extent of cell growth (GO:0061387) | 2.88369240 |
| 102 | chaperone-mediated protein transport (GO:0072321) | 2.86075348 |
| 103 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.85963496 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85506667 |
| 105 | negative regulation of neurotransmitter transport (GO:0051589) | 2.84770864 |
| 106 | detection of calcium ion (GO:0005513) | 2.84304328 |
| 107 | chemosensory behavior (GO:0007635) | 2.83251078 |
| 108 | membrane hyperpolarization (GO:0060081) | 2.82600933 |
| 109 | negative regulation of myotube differentiation (GO:0010832) | 2.82229037 |
| 110 | regulation of histone H3-K27 methylation (GO:0061085) | 2.81847182 |
| 111 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81788611 |
| 112 | membrane depolarization during action potential (GO:0086010) | 2.81517331 |
| 113 | learning (GO:0007612) | 2.81083775 |
| 114 | regulation of synaptic plasticity (GO:0048167) | 2.80333485 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.78208759 |
| 116 | synapse organization (GO:0050808) | 2.78135406 |
| 117 | regulation of synapse organization (GO:0050807) | 2.78082899 |
| 118 | leukocyte aggregation (GO:0070486) | 2.77396626 |
| 119 | cellular potassium ion homeostasis (GO:0030007) | 2.77102736 |
| 120 | fear response (GO:0042596) | 2.74356658 |
| 121 | L-amino acid import (GO:0043092) | 2.74155579 |
| 122 | innervation (GO:0060384) | 2.73817326 |
| 123 | myelination (GO:0042552) | 2.73762661 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.73398614 |
| 125 | synaptic vesicle endocytosis (GO:0048488) | 2.73162940 |
| 126 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.72764318 |
| 127 | gamma-aminobutyric acid transport (GO:0015812) | 2.72210573 |
| 128 | activation of JUN kinase activity (GO:0007257) | 2.72197173 |
| 129 | positive regulation of Rap GTPase activity (GO:0032854) | 2.71750932 |
| 130 | neurotransmitter transport (GO:0006836) | 2.71198380 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.70733470 |
| 132 | adult walking behavior (GO:0007628) | 2.70258005 |
| 133 | neuron remodeling (GO:0016322) | 2.69835778 |
| 134 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.69199170 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68695690 |
| 136 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.68250302 |
| 137 | regulation of neurotransmitter secretion (GO:0046928) | 2.68101655 |
| 138 | ensheathment of neurons (GO:0007272) | 2.67787712 |
| 139 | axon ensheathment (GO:0008366) | 2.67787712 |
| 140 | calcium ion-dependent exocytosis (GO:0017156) | 2.66025531 |
| 141 | regulation of catecholamine metabolic process (GO:0042069) | 2.65725740 |
| 142 | regulation of dopamine metabolic process (GO:0042053) | 2.65725740 |
| 143 | auditory behavior (GO:0031223) | 2.64898057 |
| 144 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.64863961 |
| 145 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.63971949 |
| 146 | positive regulation of action potential (GO:0045760) | 2.63911278 |
| 147 | cellular extravasation (GO:0045123) | 2.63382587 |
| 148 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63378831 |
| 149 | positive regulation of histone deacetylation (GO:0031065) | 2.62087783 |
| 150 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60406841 |
| 151 | regulation of necroptotic process (GO:0060544) | 2.60327289 |
| 152 | response to peptidoglycan (GO:0032494) | 2.56393931 |
| 153 | histone H3-K4 trimethylation (GO:0080182) | 2.55707978 |
| 154 | histone H3-K9 demethylation (GO:0033169) | 2.54752525 |
| 155 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.53265896 |
| 156 | histone lysine demethylation (GO:0070076) | 2.50169495 |
| 157 | T cell migration (GO:0072678) | 2.48798940 |
| 158 | detection of external biotic stimulus (GO:0098581) | 2.48296064 |
| 159 | signal complex assembly (GO:0007172) | 2.47826156 |
| 160 | embryonic process involved in female pregnancy (GO:0060136) | 2.47663053 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.46473821 |
| 162 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.44542309 |
| 163 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43191053 |
| 164 | tolerance induction (GO:0002507) | 2.42749106 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41873676 |
| 166 | histone demethylation (GO:0016577) | 2.40560928 |
| 167 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40345426 |
| 168 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.40021080 |
| 169 | positive regulation of B cell differentiation (GO:0045579) | 2.39605797 |
| 170 | negative regulation of cell size (GO:0045792) | 2.39161673 |
| 171 | histone H4 deacetylation (GO:0070933) | 2.37586281 |
| 172 | positive regulation of granulocyte differentiation (GO:0030854) | 2.36843991 |
| 173 | response to interleukin-15 (GO:0070672) | 2.36686350 |
| 174 | semaphorin-plexin signaling pathway (GO:0071526) | 2.35380739 |
| 175 | modulation by virus of host process (GO:0019054) | 2.32954376 |
| 176 | positive regulation of protein deacetylation (GO:0090312) | 2.32315609 |
| 177 | modulation by symbiont of host cellular process (GO:0044068) | 2.31395767 |
| 178 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.31199537 |
| 179 | response to type I interferon (GO:0034340) | 2.29837401 |
| 180 | negative regulation of granulocyte differentiation (GO:0030853) | 2.29533614 |
| 181 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28821037 |
| 182 | activation of Rac GTPase activity (GO:0032863) | 2.28212009 |
| 183 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25577533 |
| 184 | regulation of granulocyte differentiation (GO:0030852) | 2.24859069 |
| 185 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.22649277 |
| 186 | cellular response to virus (GO:0098586) | 2.21997002 |
| 187 | regulation of Rap GTPase activity (GO:0032317) | 2.21444266 |
| 188 | type I interferon signaling pathway (GO:0060337) | 2.20734914 |
| 189 | cellular response to type I interferon (GO:0071357) | 2.20734914 |
| 190 | negative regulation of interleukin-8 production (GO:0032717) | 2.19916956 |
| 191 | negative regulation of fatty acid transport (GO:2000192) | 2.19830616 |
| 192 | regulation of extracellular matrix disassembly (GO:0010715) | 2.18213038 |
| 193 | negative regulation of innate immune response (GO:0045824) | 2.18213010 |
| 194 | cell-substrate adherens junction assembly (GO:0007045) | 2.18074873 |
| 195 | focal adhesion assembly (GO:0048041) | 2.18074873 |
| 196 | response to host defenses (GO:0052200) | 2.17644925 |
| 197 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.17644925 |
| 198 | response to host (GO:0075136) | 2.17644925 |
| 199 | detection of biotic stimulus (GO:0009595) | 2.16219039 |
| 200 | detection of molecule of bacterial origin (GO:0032490) | 2.15895389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.50584435 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.59945625 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.46819907 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10214899 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.09365919 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 3.04209521 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99044571 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96565587 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.77740944 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.70999958 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.66549822 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.61658099 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61322470 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.58414315 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56854217 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56854217 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54488582 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53206452 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49369091 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46706109 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44430882 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.43897657 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39560748 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39435560 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38733702 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.33165890 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30900370 |
| 28 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28058610 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.26243893 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26083981 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.25572067 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24896558 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.15603206 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.13469963 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.11277370 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11133676 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08364475 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05894713 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01492351 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.00617785 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99924120 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97763832 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.92487447 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92239590 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92220646 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91900017 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.90417856 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90082328 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.88403751 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.87913304 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86219119 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85896183 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85269766 |
| 54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81714552 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78195378 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75663404 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73199598 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71192296 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70216299 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67932714 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.67538115 |
| 62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66576886 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.65490948 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65115659 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63299890 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.62767180 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61687244 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59778324 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59396324 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59181591 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59024397 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56687904 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55104944 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54942545 |
| 75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54908100 |
| 76 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53953679 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53686124 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53450206 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.52032027 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51736824 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50392278 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47379965 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47325818 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46657277 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46263319 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46139218 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45995822 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44140138 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.43447591 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43413971 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42693620 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42616351 |
| 93 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41999044 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.39522750 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39323658 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38199513 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37640310 |
| 98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.37458022 |
| 99 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34620803 |
| 100 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33476560 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32090686 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30672579 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30464238 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29073972 |
| 105 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28206587 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28068160 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 1.26875930 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26724524 |
| 109 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26443724 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26092171 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25624791 |
| 112 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25244893 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24792167 |
| 114 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24727291 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23765443 |
| 116 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23579704 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23529635 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22668539 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22488709 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22388547 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20151512 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19932138 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19915264 |
| 124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18870634 |
| 125 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.18429153 |
| 126 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.18379549 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18239419 |
| 128 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17259513 |
| 129 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16560875 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16158543 |
| 131 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15110052 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14990912 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14984338 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14023044 |
| 135 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13641891 |
| 136 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12788412 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12663406 |
| 138 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12006090 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11071266 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11013809 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10322564 |
| 142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10023350 |
| 143 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09926518 |
| 144 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09752003 |
| 145 | MYB_26560356_Chip-Seq_TH2_Human | 1.09520676 |
| 146 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.09176359 |
| 147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07878839 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07724547 |
| 149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07554366 |
| 150 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07235663 |
| 151 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07128849 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06624229 |
| 153 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06320574 |
| 154 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05908694 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05659694 |
| 156 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05637715 |
| 157 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04819482 |
| 158 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04774886 |
| 159 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04558194 |
| 160 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02197851 |
| 161 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02162640 |
| 162 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00325185 |
| 163 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99430101 |
| 164 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99325741 |
| 165 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98623967 |
| 166 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98223833 |
| 167 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98114882 |
| 168 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98114882 |
| 169 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97899914 |
| 170 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97483790 |
| 171 | AR_19668381_ChIP-Seq_PC3_Human | 0.97326815 |
| 172 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96513156 |
| 173 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95608261 |
| 174 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95310141 |
| 175 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95295782 |
| 176 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95181322 |
| 177 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94777157 |
| 178 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94475912 |
| 179 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93490733 |
| 180 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93252382 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93010436 |
| 182 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91371717 |
| 183 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90563847 |
| 184 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90183785 |
| 185 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89687472 |
| 186 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88951864 |
| 187 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85571759 |
| 188 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85356987 |
| 189 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83114748 |
| 190 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82855341 |
| 191 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82198745 |
| 192 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80992359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.37443556 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.00826273 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.78215817 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.59461907 |
| 5 | MP0004270_analgesia | 3.43314340 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.26586718 |
| 7 | MP0003436_decreased_susceptibility_to | 3.23115253 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.02655856 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.99106818 |
| 10 | MP0003303_peritoneal_inflammation | 2.98736239 |
| 11 | MP0009745_abnormal_behavioral_response | 2.96830286 |
| 12 | MP0002064_seizures | 2.80640485 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.75698001 |
| 14 | MP0001486_abnormal_startle_reflex | 2.69678560 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.64308436 |
| 16 | MP0009046_muscle_twitch | 2.61029770 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.53303705 |
| 18 | MP0009278_abnormal_bone_marrow | 2.53025575 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.50058978 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.38910860 |
| 21 | MP0004381_abnormal_hair_follicle | 2.37813266 |
| 22 | MP0002272_abnormal_nervous_system | 2.37702420 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.30893683 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.28918656 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.25471372 |
| 26 | MP0005451_abnormal_body_composition | 2.17472771 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.16953021 |
| 28 | MP0001800_abnormal_humoral_immune | 2.14857920 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 2.12260435 |
| 30 | MP0002184_abnormal_innervation | 2.12245615 |
| 31 | MP0000685_abnormal_immune_system | 2.12231689 |
| 32 | MP0004947_skin_inflammation | 2.11899261 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 2.08999017 |
| 34 | MP0008260_abnormal_autophagy | 2.04613599 |
| 35 | MP0001502_abnormal_circadian_rhythm | 2.04609815 |
| 36 | MP0003137_abnormal_impulse_conducting | 2.03388263 |
| 37 | MP0001440_abnormal_grooming_behavior | 2.03078465 |
| 38 | MP0005409_darkened_coat_color | 1.91384944 |
| 39 | MP0002419_abnormal_innate_immunity | 1.90050248 |
| 40 | MP0005025_abnormal_response_to | 1.89878296 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.89762946 |
| 42 | MP0005387_immune_system_phenotype | 1.89091303 |
| 43 | MP0001790_abnormal_immune_system | 1.89091303 |
| 44 | MP0001529_abnormal_vocalization | 1.88258772 |
| 45 | MP0000778_abnormal_nervous_system | 1.85752309 |
| 46 | MP0001873_stomach_inflammation | 1.83825321 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.82330763 |
| 48 | MP0003091_abnormal_cell_migration | 1.81973226 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.81646430 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.79075916 |
| 51 | MP0000920_abnormal_myelination | 1.79035138 |
| 52 | MP0001905_abnormal_dopamine_level | 1.76095677 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.76093876 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.75406864 |
| 55 | MP0001970_abnormal_pain_threshold | 1.75273707 |
| 56 | MP0002723_abnormal_immune_serum | 1.74599265 |
| 57 | MP0001819_abnormal_immune_cell | 1.74387005 |
| 58 | MP0002736_abnormal_nociception_after | 1.73008845 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.70021959 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.69588969 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.67691931 |
| 62 | MP0003329_amyloid_beta_deposits | 1.65595759 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.61625013 |
| 64 | MP0001849_ear_inflammation | 1.61344148 |
| 65 | MP0004142_abnormal_muscle_tone | 1.58904502 |
| 66 | MP0002398_abnormal_bone_marrow | 1.58016103 |
| 67 | MP0001984_abnormal_olfaction | 1.55832028 |
| 68 | MP0005671_abnormal_response_to | 1.54465858 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.53945559 |
| 70 | MP0003724_increased_susceptibility_to | 1.53855139 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.52537338 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.52197564 |
| 73 | MP0000751_myopathy | 1.51565458 |
| 74 | MP0002933_joint_inflammation | 1.50189167 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.49783132 |
| 76 | MP0004924_abnormal_behavior | 1.49783132 |
| 77 | MP0002822_catalepsy | 1.49056472 |
| 78 | MP0002405_respiratory_system_inflammati | 1.48620791 |
| 79 | MP0000716_abnormal_immune_system | 1.46108158 |
| 80 | MP0002882_abnormal_neuron_morphology | 1.45803044 |
| 81 | MP0008569_lethality_at_weaning | 1.42915201 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.41663286 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.41583302 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 1.41323260 |
| 85 | MP0009840_abnormal_foam_cell | 1.40778001 |
| 86 | MP0004742_abnormal_vestibular_system | 1.40704642 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.39501632 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.39053953 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.38588702 |
| 90 | MP0004085_abnormal_heartbeat | 1.38263326 |
| 91 | MP0000955_abnormal_spinal_cord | 1.35886641 |
| 92 | MP0003866_abnormal_defecation | 1.35323649 |
| 93 | MP0001851_eye_inflammation | 1.30002218 |
| 94 | MP0003879_abnormal_hair_cell | 1.29809211 |
| 95 | MP0005464_abnormal_platelet_physiology | 1.29773518 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 1.29185038 |
| 97 | MP0003690_abnormal_glial_cell | 1.29141507 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 1.28707573 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 1.27840388 |
| 100 | MP0004885_abnormal_endolymph | 1.25949600 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 1.25324165 |
| 102 | MP0001545_abnormal_hematopoietic_system | 1.25324165 |
| 103 | MP0001188_hyperpigmentation | 1.24539075 |
| 104 | MP0001958_emphysema | 1.23352703 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 1.22876554 |
| 106 | MP0003950_abnormal_plasma_membrane | 1.21992285 |
| 107 | MP0003183_abnormal_peptide_metabolism | 1.20723690 |
| 108 | MP0002722_abnormal_immune_system | 1.19948548 |
| 109 | MP0003634_abnormal_glial_cell | 1.19533170 |
| 110 | MP0002909_abnormal_adrenal_gland | 1.17833755 |
| 111 | MP0002429_abnormal_blood_cell | 1.17296380 |
| 112 | MP0002229_neurodegeneration | 1.16996845 |
| 113 | MP0002166_altered_tumor_susceptibility | 1.15134584 |
| 114 | MP0005666_abnormal_adipose_tissue | 1.13026671 |
| 115 | MP0000858_altered_metastatic_potential | 1.12793878 |
| 116 | MP0002009_preneoplasia | 1.11436618 |
| 117 | MP0004811_abnormal_neuron_physiology | 1.09953224 |
| 118 | MP0000015_abnormal_ear_pigmentation | 1.08854137 |
| 119 | MP0003279_aneurysm | 1.08260718 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 1.06360731 |
| 121 | MP0000689_abnormal_spleen_morphology | 1.06243200 |
| 122 | MP0005310_abnormal_salivary_gland | 1.05735579 |
| 123 | MP0002152_abnormal_brain_morphology | 1.05247430 |
| 124 | MP0002752_abnormal_somatic_nervous | 1.04851636 |
| 125 | MP0001963_abnormal_hearing_physiology | 1.04593556 |
| 126 | MP0000566_synostosis | 1.03543624 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.99824910 |
| 128 | MP0002163_abnormal_gland_morphology | 0.99491636 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.99025789 |
| 130 | MP0004036_abnormal_muscle_relaxation | 0.97079572 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.96723700 |
| 132 | MP0003828_pulmonary_edema | 0.96297662 |
| 133 | MP0003633_abnormal_nervous_system | 0.95610811 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.95157194 |
| 135 | MP0009785_altered_susceptibility_to | 0.95077068 |
| 136 | MP0006082_CNS_inflammation | 0.94747552 |
| 137 | MP0009379_abnormal_foot_pigmentation | 0.93855984 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.93637050 |
| 139 | MP0006072_abnormal_retinal_apoptosis | 0.92420604 |
| 140 | MP0001986_abnormal_taste_sensitivity | 0.92284813 |
| 141 | MP0003631_nervous_system_phenotype | 0.91436747 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.91223698 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.89935652 |
| 144 | MP0002638_abnormal_pupillary_reflex | 0.88728009 |
| 145 | MP0005621_abnormal_cell_physiology | 0.86261323 |
| 146 | MP0004858_abnormal_nervous_system | 0.85167701 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.84786655 |
| 148 | MP0002148_abnormal_hypersensitivity_rea | 0.82444221 |
| 149 | MP0005535_abnormal_body_temperature | 0.82200348 |
| 150 | MP0002069_abnormal_eating/drinking_beha | 0.81840268 |
| 151 | MP0003632_abnormal_nervous_system | 0.81316977 |
| 152 | MP0000733_abnormal_muscle_development | 0.80057346 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.79988871 |
| 154 | MP0008874_decreased_physiological_sensi | 0.79508132 |
| 155 | MP0010386_abnormal_urinary_bladder | 0.77818458 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.77369991 |
| 157 | MP0004215_abnormal_myocardial_fiber | 0.76695298 |
| 158 | MP0005023_abnormal_wound_healing | 0.75901078 |
| 159 | MP0000749_muscle_degeneration | 0.75717364 |
| 160 | MP0000604_amyloidosis | 0.74618954 |
| 161 | MP0000747_muscle_weakness | 0.74214559 |
| 162 | MP0009931_abnormal_skin_appearance | 0.73965612 |
| 163 | MP0003122_maternal_imprinting | 0.73186985 |
| 164 | MP0005195_abnormal_posterior_eye | 0.72836776 |
| 165 | MP0000249_abnormal_blood_vessel | 0.72699494 |
| 166 | MP0000026_abnormal_inner_ear | 0.72611335 |
| 167 | MP0009115_abnormal_fat_cell | 0.72400216 |
| 168 | MP0002090_abnormal_vision | 0.71530378 |
| 169 | MP0001348_abnormal_lacrimal_gland | 0.70508360 |
| 170 | MP0003075_altered_response_to | 0.70212904 |
| 171 | MP0004130_abnormal_muscle_cell | 0.68588670 |
| 172 | MP0000767_abnormal_smooth_muscle | 0.68500053 |
| 173 | MP0005171_absent_coat_pigmentation | 0.67653116 |
| 174 | MP0008469_abnormal_protein_level | 0.66554647 |
| 175 | MP0003136_yellow_coat_color | 0.66438021 |
| 176 | MP0003656_abnormal_erythrocyte_physiolo | 0.66212354 |
| 177 | MP0002132_abnormal_respiratory_system | 0.65662865 |
| 178 | MP0005253_abnormal_eye_physiology | 0.65037308 |
| 179 | MP0004510_myositis | 0.64571881 |
| 180 | MP0004883_abnormal_blood_vessel | 0.64403598 |
| 181 | MP0003045_fibrosis | 0.57942209 |
| 182 | MP0001943_abnormal_respiration | 0.56774007 |
| 183 | MP0004484_altered_response_of | 0.56385859 |
| 184 | MP0005410_abnormal_fertilization | 0.56025154 |
| 185 | MP0003938_abnormal_ear_development | 0.52931793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Overriding aorta (HP:0002623) | 5.87956111 |
| 2 | Insomnia (HP:0100785) | 5.77929384 |
| 3 | Elfin facies (HP:0004428) | 5.58785139 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 5.51679080 |
| 5 | Hyperacusis (HP:0010780) | 5.50586301 |
| 6 | Myokymia (HP:0002411) | 5.12761125 |
| 7 | Renovascular hypertension (HP:0100817) | 4.81580155 |
| 8 | Flat cornea (HP:0007720) | 4.79623572 |
| 9 | Focal motor seizures (HP:0011153) | 4.50567795 |
| 10 | Focal seizures (HP:0007359) | 4.30091072 |
| 11 | Amyotrophic lateral sclerosis (HP:0007354) | 4.21367305 |
| 12 | Renal duplication (HP:0000075) | 4.04974334 |
| 13 | Abnormality of the diencephalon (HP:0010662) | 3.75646373 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.74405851 |
| 15 | Visual hallucinations (HP:0002367) | 3.66943185 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.63384831 |
| 17 | Obstructive sleep apnea (HP:0002870) | 3.58530417 |
| 18 | Atonic seizures (HP:0010819) | 3.47793406 |
| 19 | Sensory axonal neuropathy (HP:0003390) | 3.44607274 |
| 20 | Abnormality of the fingertips (HP:0001211) | 3.44544590 |
| 21 | Broad face (HP:0000283) | 3.38033360 |
| 22 | Absence seizures (HP:0002121) | 3.34842017 |
| 23 | Colitis (HP:0002583) | 3.33219070 |
| 24 | Epileptic encephalopathy (HP:0200134) | 3.29487106 |
| 25 | Megalocornea (HP:0000485) | 3.26004252 |
| 26 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.23850803 |
| 27 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.23850803 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.19021977 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 3.12884013 |
| 30 | Febrile seizures (HP:0002373) | 3.07518928 |
| 31 | Rimmed vacuoles (HP:0003805) | 3.02451481 |
| 32 | Dialeptic seizures (HP:0011146) | 2.97748172 |
| 33 | Cerebral aneurysm (HP:0004944) | 2.90077012 |
| 34 | Shoulder girdle muscle weakness (HP:0003547) | 2.90056231 |
| 35 | Spastic gait (HP:0002064) | 2.89815270 |
| 36 | Abnormality of the corticospinal tract (HP:0002492) | 2.89278269 |
| 37 | Thin bony cortex (HP:0002753) | 2.88340888 |
| 38 | Increased IgE level (HP:0003212) | 2.81971815 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.76084447 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 2.75734143 |
| 41 | Bladder diverticulum (HP:0000015) | 2.71861881 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.70264166 |
| 43 | Broad-based gait (HP:0002136) | 2.70044087 |
| 44 | Ankle clonus (HP:0011448) | 2.67011869 |
| 45 | Cellulitis (HP:0100658) | 2.65620633 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.62566458 |
| 47 | Abnormality of the vocal cords (HP:0008777) | 2.58854046 |
| 48 | Papilledema (HP:0001085) | 2.54045942 |
| 49 | Patellar dislocation (HP:0002999) | 2.49771012 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.47837807 |
| 51 | Bowel diverticulosis (HP:0005222) | 2.47833613 |
| 52 | Synostosis involving the elbow (HP:0003938) | 2.47602246 |
| 53 | Humeroradial synostosis (HP:0003041) | 2.47602246 |
| 54 | Upper motor neuron abnormality (HP:0002127) | 2.43240649 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.39214516 |
| 56 | Hyperventilation (HP:0002883) | 2.38802156 |
| 57 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.38409985 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.37813992 |
| 59 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.33948903 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.33773360 |
| 61 | Gingivitis (HP:0000230) | 2.29743190 |
| 62 | Dysmetria (HP:0001310) | 2.29384540 |
| 63 | Action tremor (HP:0002345) | 2.28550354 |
| 64 | Parakeratosis (HP:0001036) | 2.26572502 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.25857309 |
| 66 | Flat acetabular roof (HP:0003180) | 2.23814396 |
| 67 | Pustule (HP:0200039) | 2.23720211 |
| 68 | Thoracic kyphosis (HP:0002942) | 2.23653943 |
| 69 | Abnormality of the thoracic spine (HP:0100711) | 2.23387089 |
| 70 | Abnormality of secondary sexual hair (HP:0009888) | 2.22285939 |
| 71 | Abnormality of the axillary hair (HP:0100134) | 2.22285939 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21560691 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.21560691 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.21186161 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.19189741 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.19050624 |
| 77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18534849 |
| 78 | Cervical subluxation (HP:0003308) | 2.18324375 |
| 79 | Arnold-Chiari malformation (HP:0002308) | 2.17931226 |
| 80 | Insidious onset (HP:0003587) | 2.17842854 |
| 81 | Termporal pattern (HP:0011008) | 2.17842854 |
| 82 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17346090 |
| 83 | Hemiparesis (HP:0001269) | 2.17252874 |
| 84 | Annular pancreas (HP:0001734) | 2.15973441 |
| 85 | Agammaglobulinemia (HP:0004432) | 2.15726289 |
| 86 | Hypercalcemia (HP:0003072) | 2.15319026 |
| 87 | Periorbital edema (HP:0100539) | 2.14801266 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13648064 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13648064 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13648064 |
| 91 | Gastrointestinal infarctions (HP:0005244) | 2.13202007 |
| 92 | Progressive inability to walk (HP:0002505) | 2.12426388 |
| 93 | Mediastinal lymphadenopathy (HP:0100721) | 2.11342094 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.10043222 |
| 95 | Facial edema (HP:0000282) | 2.09674568 |
| 96 | Meningitis (HP:0001287) | 2.09508395 |
| 97 | Abnormality of macrophages (HP:0004311) | 2.09307703 |
| 98 | Slow saccadic eye movements (HP:0000514) | 2.09213069 |
| 99 | Scanning speech (HP:0002168) | 2.07389297 |
| 100 | Recurrent viral infections (HP:0004429) | 2.06752948 |
| 101 | Posterior embryotoxon (HP:0000627) | 2.06599174 |
| 102 | Dislocated radial head (HP:0003083) | 2.06041186 |
| 103 | Emphysema (HP:0002097) | 2.06009418 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05970969 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05970969 |
| 106 | Calf muscle hypertrophy (HP:0008981) | 2.04531151 |
| 107 | Hypercalciuria (HP:0002150) | 2.03700857 |
| 108 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03306867 |
| 109 | Lower limb muscle weakness (HP:0007340) | 2.01993721 |
| 110 | Myositis (HP:0100614) | 2.01576618 |
| 111 | Anxiety (HP:0000739) | 2.00551901 |
| 112 | Epileptiform EEG discharges (HP:0011182) | 1.99718518 |
| 113 | Polyphagia (HP:0002591) | 1.97483975 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.95360872 |
| 115 | Abnormality of the line of Schwalbe (HP:0008048) | 1.94669313 |
| 116 | Palpebral edema (HP:0100540) | 1.93088431 |
| 117 | Drooling (HP:0002307) | 1.92700829 |
| 118 | Excessive salivation (HP:0003781) | 1.92700829 |
| 119 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92391000 |
| 120 | Abnormality of the radial head (HP:0003995) | 1.91959785 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 1.91616907 |
| 122 | Myotonia (HP:0002486) | 1.91160571 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90910867 |
| 124 | Neuronal loss in central nervous system (HP:0002529) | 1.90676298 |
| 125 | Amblyopia (HP:0000646) | 1.89281467 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88979197 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88979197 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88979197 |
| 129 | Aneurysm (HP:0002617) | 1.88349764 |
| 130 | Chest pain (HP:0100749) | 1.88288034 |
| 131 | Prolonged bleeding time (HP:0003010) | 1.87167823 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.87123896 |
| 133 | Urinary urgency (HP:0000012) | 1.86886620 |
| 134 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86669684 |
| 135 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86467854 |
| 136 | Truncal ataxia (HP:0002078) | 1.84413324 |
| 137 | Increased cerebral lipofuscin (HP:0011813) | 1.83869150 |
| 138 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83528829 |
| 139 | Obstructive lung disease (HP:0006536) | 1.83528829 |
| 140 | J-shaped sella turcica (HP:0002680) | 1.83222570 |
| 141 | Retinal dysplasia (HP:0007973) | 1.82935861 |
| 142 | Peripheral hypomyelination (HP:0007182) | 1.82685138 |
| 143 | Epistaxis (HP:0000421) | 1.82041445 |
| 144 | Ulnar bowing (HP:0003031) | 1.81371959 |
| 145 | Onion bulb formation (HP:0003383) | 1.80998225 |
| 146 | Polygenic inheritance (HP:0010982) | 1.80409862 |
| 147 | Abnormality of macular pigmentation (HP:0008002) | 1.79836052 |
| 148 | Abnormality of the columella (HP:0009929) | 1.79432439 |
| 149 | Viral hepatitis (HP:0006562) | 1.79192928 |
| 150 | Deformed sella turcica (HP:0002681) | 1.76737369 |
| 151 | Gastrointestinal stroma tumor (HP:0100723) | 1.76165519 |
| 152 | Supernumerary nipples (HP:0002558) | 1.75090629 |
| 153 | Bulbar palsy (HP:0001283) | 1.75078198 |
| 154 | Increased connective tissue (HP:0009025) | 1.73714883 |
| 155 | Recurrent skin infections (HP:0001581) | 1.73531447 |
| 156 | Hallux valgus (HP:0001822) | 1.72681575 |
| 157 | Gait imbalance (HP:0002141) | 1.72529644 |
| 158 | Joint stiffness (HP:0001387) | 1.71484022 |
| 159 | Restrictive lung disease (HP:0002091) | 1.71399675 |
| 160 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.71064480 |
| 161 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.70858509 |
| 162 | Pointed chin (HP:0000307) | 1.70571399 |
| 163 | Hypsarrhythmia (HP:0002521) | 1.70396046 |
| 164 | Hypoplasia of the iris (HP:0007676) | 1.70137521 |
| 165 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70055356 |
| 166 | Rapidly progressive (HP:0003678) | 1.69749142 |
| 167 | Increased circulating renin level (HP:0000848) | 1.68919275 |
| 168 | Spondylolisthesis (HP:0003302) | 1.68878979 |
| 169 | Poor eye contact (HP:0000817) | 1.68778169 |
| 170 | Vasculitis (HP:0002633) | 1.67853424 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.67696197 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.67696197 |
| 173 | Abnormality of binocular vision (HP:0011514) | 1.67687742 |
| 174 | Diplopia (HP:0000651) | 1.67687742 |
| 175 | Biconcave vertebral bodies (HP:0004586) | 1.67654586 |
| 176 | Dysmetric saccades (HP:0000641) | 1.67625574 |
| 177 | Obsessive-compulsive behavior (HP:0000722) | 1.67607250 |
| 178 | Absent speech (HP:0001344) | 1.67509092 |
| 179 | Clonus (HP:0002169) | 1.67263615 |
| 180 | Spinal cord lesions (HP:0100561) | 1.67087085 |
| 181 | Syringomyelia (HP:0003396) | 1.67087085 |
| 182 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65370757 |
| 183 | Metaphyseal cupping (HP:0003021) | 1.63988033 |
| 184 | Germ cell neoplasia (HP:0100728) | 1.63702661 |
| 185 | Mitral regurgitation (HP:0001653) | 1.62876594 |
| 186 | Asymmetry of the thorax (HP:0001555) | 1.62707346 |
| 187 | Papilloma (HP:0012740) | 1.62100717 |
| 188 | Verrucae (HP:0200043) | 1.62100717 |
| 189 | Turricephaly (HP:0000262) | 1.61276528 |
| 190 | Vertebral arch anomaly (HP:0008438) | 1.61103104 |
| 191 | Protrusio acetabuli (HP:0003179) | 1.60468204 |
| 192 | Long eyelashes (HP:0000527) | 1.59876829 |
| 193 | Disproportionate tall stature (HP:0001519) | 1.58919427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LIMK1 | 7.82825334 |
| 2 | TRIB3 | 4.21312149 |
| 3 | CDC42BPA | 3.55959230 |
| 4 | MARK1 | 3.25145761 |
| 5 | EPHA4 | 3.01702116 |
| 6 | NTRK2 | 2.98260351 |
| 7 | NTRK3 | 2.84367720 |
| 8 | ERN1 | 2.80667158 |
| 9 | CDK12 | 2.78690569 |
| 10 | MAP4K1 | 2.60542969 |
| 11 | CASK | 2.40587941 |
| 12 | PNCK | 2.17122928 |
| 13 | SIK1 | 2.15994321 |
| 14 | ROCK2 | 2.09962753 |
| 15 | SMG1 | 2.02991012 |
| 16 | TNIK | 2.00730550 |
| 17 | RIPK1 | 1.94674178 |
| 18 | FGFR4 | 1.88932247 |
| 19 | NTRK1 | 1.83891349 |
| 20 | MAP3K13 | 1.83666448 |
| 21 | EEF2K | 1.76228914 |
| 22 | MAP3K10 | 1.75443549 |
| 23 | MAP2K3 | 1.72176275 |
| 24 | PKN2 | 1.69853458 |
| 25 | STK39 | 1.66988806 |
| 26 | PAK6 | 1.64557513 |
| 27 | ZAP70 | 1.63768030 |
| 28 | RIPK4 | 1.63688659 |
| 29 | OXSR1 | 1.63179590 |
| 30 | FES | 1.61654602 |
| 31 | TYK2 | 1.61226645 |
| 32 | ARAF | 1.58991734 |
| 33 | MINK1 | 1.58982646 |
| 34 | MAP3K9 | 1.57181541 |
| 35 | CAMKK1 | 1.47151917 |
| 36 | BCR | 1.37972603 |
| 37 | MAP3K4 | 1.34319152 |
| 38 | MAP3K7 | 1.30969424 |
| 39 | CDK5 | 1.30196503 |
| 40 | UHMK1 | 1.28973952 |
| 41 | EPHB1 | 1.25474255 |
| 42 | PKN1 | 1.24327390 |
| 43 | ROCK1 | 1.23235174 |
| 44 | PHKG2 | 1.21856079 |
| 45 | PHKG1 | 1.21856079 |
| 46 | BTK | 1.20911210 |
| 47 | MAP3K14 | 1.19173912 |
| 48 | FGFR3 | 1.15638155 |
| 49 | GRK6 | 1.14562658 |
| 50 | TYRO3 | 1.14199454 |
| 51 | GRK5 | 1.13470406 |
| 52 | MAPK13 | 1.12717468 |
| 53 | CAMK2D | 1.12238402 |
| 54 | TBK1 | 1.12098822 |
| 55 | JAK1 | 1.11373313 |
| 56 | CDK19 | 1.10976686 |
| 57 | JAK3 | 1.09611913 |
| 58 | CSK | 1.03512120 |
| 59 | MTOR | 1.02377548 |
| 60 | PDGFRA | 1.01567636 |
| 61 | CAMK2B | 1.01078557 |
| 62 | CAMK2A | 0.99545161 |
| 63 | FGR | 0.98086169 |
| 64 | HIPK2 | 0.97657411 |
| 65 | IKBKE | 0.97526812 |
| 66 | IRAK4 | 0.96931230 |
| 67 | DAPK2 | 0.95622773 |
| 68 | TTN | 0.94704852 |
| 69 | MUSK | 0.94298299 |
| 70 | SIK2 | 0.93574496 |
| 71 | PLK2 | 0.92201065 |
| 72 | MAPK11 | 0.91031892 |
| 73 | MAP2K7 | 0.90358167 |
| 74 | MAP3K1 | 0.90118619 |
| 75 | SYK | 0.89138240 |
| 76 | HCK | 0.89056591 |
| 77 | PRKCE | 0.86162433 |
| 78 | BMPR2 | 0.84733182 |
| 79 | MAP3K6 | 0.83790602 |
| 80 | PAK3 | 0.82133523 |
| 81 | PTK6 | 0.81836222 |
| 82 | PDK1 | 0.81354573 |
| 83 | PRPF4B | 0.80509986 |
| 84 | MAP3K3 | 0.79374458 |
| 85 | SGK3 | 0.79301016 |
| 86 | PTK2B | 0.79029303 |
| 87 | PRKCG | 0.77998545 |
| 88 | ITK | 0.77663658 |
| 89 | MAPK7 | 0.77231286 |
| 90 | SIK3 | 0.75599723 |
| 91 | CSF1R | 0.75523245 |
| 92 | IRAK2 | 0.75261879 |
| 93 | MST1R | 0.74599102 |
| 94 | KSR1 | 0.73191429 |
| 95 | CAMK1D | 0.73102323 |
| 96 | IRAK3 | 0.73050275 |
| 97 | GRK7 | 0.71009964 |
| 98 | LCK | 0.70752403 |
| 99 | DMPK | 0.70481068 |
| 100 | NME1 | 0.70409894 |
| 101 | ADRBK2 | 0.70163837 |
| 102 | TNK2 | 0.70054818 |
| 103 | PRKD3 | 0.69641926 |
| 104 | STK38 | 0.68858220 |
| 105 | FGFR2 | 0.68408948 |
| 106 | MAP3K12 | 0.67710518 |
| 107 | KIT | 0.66926121 |
| 108 | RPS6KL1 | 0.66553493 |
| 109 | RPS6KC1 | 0.66553493 |
| 110 | JAK2 | 0.66076941 |
| 111 | CDK4 | 0.64704016 |
| 112 | PDGFRB | 0.64422178 |
| 113 | MAP3K11 | 0.63810369 |
| 114 | SGK1 | 0.63237605 |
| 115 | WNK4 | 0.62774108 |
| 116 | ICK | 0.62399400 |
| 117 | FER | 0.60514302 |
| 118 | KSR2 | 0.59655513 |
| 119 | BRD4 | 0.59113654 |
| 120 | TAOK1 | 0.58883965 |
| 121 | MAPKAPK5 | 0.58053751 |
| 122 | SGK494 | 0.54221154 |
| 123 | SGK223 | 0.54221154 |
| 124 | DYRK2 | 0.53420006 |
| 125 | WNK1 | 0.53375964 |
| 126 | MARK3 | 0.52334979 |
| 127 | PRKCQ | 0.52093226 |
| 128 | INSRR | 0.52019842 |
| 129 | CAMK2G | 0.51319075 |
| 130 | RPS6KA6 | 0.51272386 |
| 131 | DYRK1A | 0.49059036 |
| 132 | CAMK1G | 0.48460020 |
| 133 | CDK18 | 0.48367903 |
| 134 | SGK2 | 0.47989020 |
| 135 | LYN | 0.47815876 |
| 136 | CDK6 | 0.47765905 |
| 137 | CHUK | 0.47574183 |
| 138 | RET | 0.47569059 |
| 139 | CDK14 | 0.47552430 |
| 140 | LRRK2 | 0.47476999 |
| 141 | STK24 | 0.46631466 |
| 142 | PRKD2 | 0.46546100 |
| 143 | CAMK4 | 0.46189110 |
| 144 | MAP2K4 | 0.46028209 |
| 145 | CSNK1G2 | 0.46016796 |
| 146 | PRKACA | 0.45876929 |
| 147 | CAMK1 | 0.45870187 |
| 148 | NEK6 | 0.45472273 |
| 149 | MELK | 0.45098187 |
| 150 | CDK15 | 0.44866184 |
| 151 | MAP2K6 | 0.44702167 |
| 152 | DYRK1B | 0.44567434 |
| 153 | PAK1 | 0.44408885 |
| 154 | BLK | 0.43580168 |
| 155 | FYN | 0.43420235 |
| 156 | DDR2 | 0.42966653 |
| 157 | CSNK1G3 | 0.42207807 |
| 158 | MAPK15 | 0.42089753 |
| 159 | MAP2K2 | 0.40821506 |
| 160 | PDPK1 | 0.40677393 |
| 161 | MARK2 | 0.40417216 |
| 162 | PRKCH | 0.40249580 |
| 163 | PRKCB | 0.39536607 |
| 164 | CDK11A | 0.36958408 |
| 165 | MAPK12 | 0.35996928 |
| 166 | CSNK1A1L | 0.35497959 |
| 167 | RPS6KA2 | 0.35136019 |
| 168 | DAPK1 | 0.34630358 |
| 169 | RPS6KA3 | 0.34577995 |
| 170 | MAPKAPK2 | 0.34495556 |
| 171 | CAMKK2 | 0.33590867 |
| 172 | MAP3K2 | 0.33463707 |
| 173 | MAP2K1 | 0.32081756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.86642403 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.89077357 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.73473488 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69905459 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56670005 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50703525 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.48135957 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39501899 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.21966015 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.12427902 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.08035344 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06557650 |
| 13 | Axon guidance_Homo sapiens_hsa04360 | 2.01748735 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01271772 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.98652666 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.97857254 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93683189 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.92868158 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91892987 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89229718 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.87261433 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.85302527 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85086742 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82153658 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.81716194 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.78175856 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75008076 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74083954 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.66258807 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.66154755 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60196268 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60061018 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58986235 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58963478 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57591058 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55888224 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52809887 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51790632 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.48599822 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47490503 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46657997 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45464619 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40013547 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37860347 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33292288 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31677084 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29689447 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25683576 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24715733 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24204307 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23774893 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20598499 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20216622 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19528358 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17356054 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17313381 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.15530443 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14102072 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13736145 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.13003057 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 1.11857342 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10742486 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10527184 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09336201 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08505894 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 1.08291835 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06890508 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06646100 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06219797 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 1.05306229 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04290114 |
| 72 | Measles_Homo sapiens_hsa05162 | 1.03635578 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03516566 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 1.03285039 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01986997 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00800469 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00790108 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00545446 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00508662 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99838344 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99797220 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97258409 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96729156 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96622160 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94588478 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91793175 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89838680 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89433080 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.88263426 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88047694 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87716910 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87510671 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86747840 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.86264158 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.86182467 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86158207 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84618813 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.84209901 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84100152 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83912768 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82940481 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80550148 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80421928 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80303629 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80188825 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.79950307 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79812227 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79481278 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79374578 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.78089626 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77965098 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.77128626 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.76841659 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76734665 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76087397 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73591603 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73121399 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73061519 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72806360 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72239405 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71828455 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.71289570 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.71055460 |
| 124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70982695 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.68943053 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68613375 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68363091 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.67825857 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66729564 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.66287689 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65952708 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62334006 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61979752 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61945176 |
| 135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61411866 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61315133 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60197078 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60068670 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.59971741 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59636017 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58153852 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57239391 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56110902 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54033143 |
| 145 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53462449 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53120399 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52031260 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50942105 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50355222 |
| 150 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45386001 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45328211 |
| 152 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43095188 |
| 153 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42589972 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42405089 |
| 155 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38214702 |
| 156 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38033859 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37013432 |
| 158 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31443464 |
| 159 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30329656 |
| 160 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26791384 |
| 161 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26451172 |
| 162 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26323840 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25186211 |
| 164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24092489 |
| 165 | Alcoholism_Homo sapiens_hsa05034 | 0.23800178 |
| 166 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22609172 |
| 167 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22461269 |
| 168 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21817992 |
| 169 | Platelet activation_Homo sapiens_hsa04611 | 0.20463499 |
| 170 | Phagosome_Homo sapiens_hsa04145 | 0.20217198 |

